Expand your testable market
Even marginal samples can become viable with QCPRECISE. Our high-purity extractions enable confident sequencing results from low-tumor-content biopsies and hard-to-analyze tissue, broadening your eligible sample base and increasing throughput without compromising quality.
Achieve micron-level precision at scale without sacrificing sensitivity
The QCPRECISE system processes 40 slides per hour with down to 50µm resolution—delivering more usable data with less manual effort.
Reduce cost of care and diagnostic risk
By increasing tumor content for molecular testing, QCPRECISE increases diagnostic accuracy. Fewer failed tests, clearer results, and higher confidence in variant calls maximize therapeutic accuracy.
Handle complex, dispersed, and small samples with ease
Tumors are not uniform—and neither are tissue samples. QCPRECISE enables precise extraction from non-contiguous or small regions of interest, ensuring that even the most complex slides yield meaningful molecular data.
Automate with confidence
By combining digital pathology with sub-50µm tissue targeting, we enable spatially resolved tumor-specific analysis—even in dispersed or mixed cellular environments—driving novel biomarker discovery from challenging samples.
.png)
